Global private equity fund Warburg Pincus is in advanced discussions to acquire Mumbai-based Koye Pharma, a drugmaker that has built its presence across women’s health, respiratory care, and anti-diabetes drugs...
Corona Remedies acquires Wokadine from DR Reddy’s Laboratories
Corona Remedies announced the acquisition of the Wokadine brand from Dr. Reddy’s Laboratories to strengthen its presence in targeted specialty segment and offer wider accessibility. The Wokadine brand is an...
Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution Process
The bankruptcy court in Mumbai has admitted the listed pharma firm, Supha Pharmachem (formerly Remedium Lifecare), to the Corporate Insolvency Resolution Process (CIRP) and has appointed Rajesh Jhunjhunwala as the...
Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution Process
The bankruptcy court in Mumbai has admitted the listed pharma firm, Supha Pharmachem (formerly Remedium Lifecare), to the Corporate Insolvency Resolution Process (CIRP) and has appointed Rajesh Jhunjhunwala as the...
Novartis to pay up to $2 billion for US biotech firm Excellergy
Swiss drugmaker Novartis will buy California-based biotech company Excellergy in a deal worth up to $2 billion, it said on Friday, extending its anti-allergy range and in line with plans to increase its U.S. focus. A...
US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore deal
US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Mumbai-based Maneesh Pharmaceuticals in a deal valued around ₹1,600–1,800 crore, sources familiar with the...
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports
Pharmaceutical company Merck is nearing a roughly $6 billion all-cash deal to acquire biotech firm Terns Pharma, the Financial Times reported on Tuesday, citing people familiar with the matter. The potential...
Gilead Sciences buys autoimmune biotech Ouro Medicines for $2.2bn
Gilead Sciences is buying autoimmune disease biotech Ouro Medicines for nearly $2.2bn as the drugmaker kick-starts a dealmaking spree emboldened by its near-record share price. The California-based company will pay...
Encube Ethicals stake sale on hold, IPO likely by 2027
Encube Ethicals has paused plans to sell a majority stake due to a valuation mismatch, said people familiar with the matter. Instead, the company is exploring the possibility of an initial public offering (IPO) by 2027...
Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa business
Strides Pharma International AG, a step‑down subsidiary of Bengaluru-based Strides Pharma Science, has entered into definitive agreements with Sandoz AG, Switzerland and its group entities for the acquisition and...
GSK to buy 35Pharma for $950 million in CEO Miel’s second major deal
GSK has agreed to pay $950 million in cash for Canadian biotech 35Pharma, it said on Wednesday, marking the second major deal new CEO Luke Miels has struck to accelerate development of new medicines at the British...
Novartis AG to sell entire 70.68% stake for ₹1,445.89 crore in India unit; stock jumps 18%
Novartis India share price surged 18% in intra-day trade on Friday, February 20, after promoter Novartis AG agreed to sell its entire stake in the company, triggering a mandatory open offer and a complete change in...
